Article Information
History
- September 9, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Aled O’Neill1,
- Monica Palanichamy Kala1,
- Tan Chee Wah1,
- Wilfried A.A. Saron1,
- Chinmay Kumar Mantri1,
- Abhay P.S. Rathore2,
- Lin-Fa Wang1,3 and
- Ashley L. St. John1,2,3,4,*
- 1Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 169857, Singapore
- 2Department of Pathology, Duke University Medical Center, Durham, North Carolina, 27705, USA
- 3SingHealth Duke-NUS Global Health Institute, Singapore
- 4Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
- ↵*Correspondence may be addressed to: Ashley St. John, Ph.D., Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, 8 College Rd., Level 9, 169857, Singapore, Tel: +65 9771-7231, Email: ashley.st.john{at}duke-nus.edu.sg
Posted September 09, 2022.
Mucosal vaccination for SARS-CoV-2 elicits superior systemic T central memory function and cross-neutralizing antibodies against variants of concern
